Advertisement
News
Subscribe to MDT Magazine News

PAREXEL International to Present at Oppenheimer Healthcare Conference and Morningstar Annual Stocks Forum

October 25, 2010 4:35 am | by Bio-Medicine.Org | Comments

BOSTON, Oct. 25 /- PAREXEL International Corporation (Nasdaq: PRXL ) announced today it will be presenting at the Oppenheimer Healthcare Conference in New York.  James Winschel, Senior Vice President and Chief Financial Officer will be making a presentation on PAREXEL at 2:45 p.m....

TOPICS:

PolyOne GLS Selected as Healthcare Industry Marketing Specialist for Santoprene™ TPV Medical Grades

October 25, 2010 4:35 am | by Bio-Medicine.Org | Comments

CLEVELAND, Oct. 25 /- PolyOne Corporation announced that PolyOne GLS Thermoplastic Elastomers has been chosen by ExxonMobil Chemical Company to be its primary marketing specialist for thermoplastic vulcanizate (TPV) medical products made using ExxonMobil Chemical's Santoprene™ TPV....

TOPICS:

Roper Industries Announces Record Third Quarter Results

October 25, 2010 4:35 am | by Bio-Medicine.Org | Comments

SARASOTA, Fla., Oct. 25 /- Roper Industries, Inc. (NYSE: ROP ) reported record results for its third quarter ended September 30, 2010.   Net earnings for the third quarter were $84 million, a 49% increase over the third quarter of 2009, and diluted earnings per share (DEPS) were...

TOPICS:
Advertisement

Adeona CEO to Provide Keynote Address at the 2010 MichBio Expo & Conference Emerging Biosciences Showcase

October 25, 2010 4:32 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., Oct. 25 /- Adeona Pharmaceuticals, Inc., (Amex: AEN ) announced today that its Chief Executive Officer, James S. Kuo, M.D., M.B.A., will provide the keynote address at the Emerging Biosciences Showcase during the 2010 MichBio Expo & Conference. The 2010 MichBio Expo...

TOPICS:

Intercell Reports Positive Results From Its Phase II Pseudomonas Aeruginosa Investigational Vaccine Study for Certain Hospital-Acquired Infections

October 25, 2010 12:33 am | by Bio-Medicine.Org | Comments

VIENNA, Oct. 25 /- Intercell AG (VSE: ICLL) today announced results from a Phase II clinical trial involving the company's investigational nosocomial vaccine candidate (IC43) against infections with the bacterium Pseudomonas aeruginosa , a leading cause of hospital-acquired infections...

TOPICS:

TearLab’s Goal Is to Make Sure There Isn’t a Dry Eye in the House

October 24, 2010 11:32 pm | by San Diego Business Journal | Comments

When James Owen first cast eyes on San Diego-based TearLab Corp.’s lab-on-a-chip approach to testing for eye disorders, he knew one major category of patients would be seeing improved results in their vision.

TOPICS:

Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010

October 24, 2010 10:31 pm | by EurekAlert | Comments

(Heart and Stroke Foundation of Canada) Summaries of a number of new Canadian Cardiovascular Society guidelines and position statements offering the most up to date information to support clinicians in practicing evidence-based medicine were released at the Canadian Cardiovascular...

TOPICS:

Alcon taps new board chairman(2)

October 24, 2010 3:46 pm | by The Associated Press | Comments

Eye care company Alcon Inc. said Sunday its board has elected a new chairman to replace Cary Rayment.Daniel Vasella, who is also chairman of the board of Novartis AG, will now take over, the company said. Vasella has served on Alcon's board since July 7, 2008, and Novartis became Alcon's...

Advertisement

Alcon taps new board chairman

October 24, 2010 3:45 pm | Comments

Eye care company Alcon Inc. said Sunday its board has elected a new chairman to replace Cary Rayment.Daniel Vasella, who is also chairman of the board of Novartis AG, will now take over, the company said. Vasella has served on Alcon's board since July 7, 2008, and Novartis became Alcon's...

Discovery of taste receptors in the lungs could help people with asthma breathe easier

October 24, 2010 11:31 am | by EurekAlert | Comments

(University of Maryland Medical Center) Taste receptors in the lungs? Researchers at the University of Maryland School of Medicine in Baltimore have discovered that bitter taste receptors are not just located in the mouth but also in human lungs. What they learned about the role of the...

TOPICS:

NCPA Announces Kathleen Jaeger as CEO

October 24, 2010 10:34 am | by Bio-Medicine.Org | Comments

ALEXANDRIA, Va., Oct. 24 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association (NCPA) today announced the appointment of Kathleen Jaeger as Executive Vice President and CEO, heralding her as an ideal choice to build on the association's recent accomplishments and lead...

TOPICS:

Hyland’s Teething Tablets: Recall - Risk of Harm to Children

October 23, 2010 8:32 pm | by U.S. Food & Drug Administration | Comments

FDA laboratory analysis found product to contain inconsistent amounts of belladonna, which can cause harm at larger doses.

Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA

October 23, 2010 9:31 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Oct. 23 /- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) announced today the presentation of combined data from its two fidaxomicin Phase 3 trials in patients with Clostridium difficile infection (CDI) at the 48th Annual Meeting of the Infectious Disease Society of America...

TOPICS:

FDA Issues Complete Response Letter for Lorcaserin New Drug Application

October 23, 2010 12:31 am | by Bio-Medicine.Org | Comments

SAN DIEGO and WOODCLIFF LAKE, N.J., Oct. 23, 2010 /- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is...

TOPICS:

VCA Antech 3Q profit drops, misses expectations

October 22, 2010 2:45 pm | by The Associated Press | Comments

VCA Antech Inc., which owns and operates veterinary hospitals and laboratories and sells premium and therapeutic pet food, said Friday that its third-quarter profit fell 25 percent as costs and expenses rose, missing analyst expectations.For July through September, VCA Antech earned $27.4...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading